The global amniotic membrane market is set to experience substantial growth, with projections estimating the market will surpass US$ 6.59 billion by 2032, up from US$ 2.44 billion in 2023. This growth reflects a CAGR of 11.68% from 2024 to 2032, driven by the increasing demand for minimally invasive (MI) treatments, the rising prevalence of chronic conditions such as rheumatoid arthritis and...

The global anxiety disorders and depression treatment market is poised for substantial growth, projected to rise from US$ 19.39 billion in 2023 to US$ 32.25 billion by 2032, at a compound annual growth rate (CAGR) of 5.82% from 2024 to 2032. This growth is being driven by a number of factors, including the rising prevalence of anxiety and depression, particularly among young adults, and the...